Research areas
► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)
► Food and Drug Administration (FDA)
► technologies (e.g., drugs, devices, AI, cybersecurity)
Metholodogical approach
► guided by economic and sociological theory
► quantitative (statistical / econometric) methods
► large administrative, survey, and other datasets
Recent Activity
>> New Publication <<
March 7, 2025
Unregulated large language models produce medical device-like output. npj Digital Medicine 2025; 4:148.
>> New Publication <<
September 20, 2024
Lessons from the Change Healthcare Ransomware Attack. JAMA Health Forum 2024; 5:e242764.
Public Comment
August 13, 2024
Comment on Optimizing the FDA’s Use of and Processes for Advisory Committees [Docket No. FDA-2024-N-1809]
BioSpace
April 21, 2025
Banning industry from FDA adcomms won’t ‘move the needle much’ in Makary, RFK’s fight against COIs
by Heather McKenzie
BioSpace
April 14, 2025
FDA after the storm: drug review delays and increased executive oversight expected
by Heather McKenzie
CNBC
March 27, 2025
US health department plans to slash 10,000 jobs as RFK Jr upends agencies
by Annika Kim Constantino